Informed Consent vs HIPAA Authorization: What’s Required and When

Ethical Principles of Informed Consent

Respect for persons and autonomy

Informed consent is an ethical commitment to respect your autonomy. It ensures you understand what will happen, why it is being done, the realistic risks and benefits, and the alternatives before you agree to participate or receive care.

Voluntariness and comprehension

You must decide freely, without coercion or undue influence. Clear language, time for questions, and teach-back methods support comprehension so your decision reflects your values and circumstances.

Ongoing communication

Consent is a continuing process, not a one-time signature. You can withdraw at any time, and researchers or clinicians should share new information that might affect your choice to continue.

Research Subject Rights

In research, informed consent centers on Research Subject Rights—privacy, the right to refuse or withdraw, access to contacts for questions or injuries, and transparency about data handling, including whether your information or biospecimens may be stored or shared in the future.

Overview of HIPAA Authorization

Purpose and scope

HIPAA authorization is a privacy permission under HIPAA Privacy Regulations that allows a covered entity to use or disclose your Protected Health Information (PHI) for purposes not otherwise permitted by the Privacy Rule. It governs PHI flows, not whether a procedure or study is ethically acceptable.

PHI Disclosure Restrictions

Without an applicable permission, HIPAA restricts uses and disclosures of PHI. A valid authorization specifies exactly what PHI may be used or disclosed, by whom, to whom, for what purpose, and for how long, aligning with PHI Disclosure Restrictions and Privacy Rule Compliance obligations.

Separate from informed consent

Informed consent and HIPAA authorization can appear in the same packet, but they serve different functions and may be required independently. You might give ethical consent to join a study yet still need to authorize PHI disclosure for research activities.

Consent under HIPAA Privacy Rule

HIPAA “consent” versus “authorization”

HIPAA does not require patient “consent” for uses and disclosures related to treatment, payment, and health care operations. Covered entities may choose to seek such consent, but it is optional under the federal rule and distinct from a HIPAA authorization.

Permitted uses and disclosures without authorization

The Privacy Rule permits certain disclosures of PHI without authorization, such as for treatment, public health reporting, health oversight, and specific research scenarios (for example, with an IRB or Privacy Board waiver, use of a limited data set under a data use agreement, or use of de-identified information). These pathways each carry precise Privacy Rule Compliance conditions.

Patient rights under HIPAA

Regardless of consent or authorization, you retain rights to access and obtain copies of your PHI, request amendments, receive an accounting of certain disclosures, and request restrictions—core safeguards separate from Research Subject Rights under informed consent.

Required Elements of Informed Consent

Core content you should see

• A clear statement that the activity is research (if applicable), its purpose, expected duration, and what you will be asked to do, distinguishing any experimental procedures.
• A balanced explanation of reasonably foreseeable risks or discomforts and the steps in place to minimize them.
• A description of potential benefits to you or to others and meaningful alternatives available to you.
• A description of how privacy and confidentiality will be protected, including plans for data storage, sharing, or future use of information or biospecimens.
• For more than minimal risk research, information about compensation and medical care available if injury occurs, and who to contact about injuries.
• Contacts for questions about the research, your rights, and research-related injuries, including how to reach the research team and the Institutional Review Board.
• A clear statement that participation is voluntary, you may refuse or withdraw without penalty or loss of benefits, and how to withdraw.
• As applicable, details about commercial profit from biospecimens, whether clinically relevant results will be returned, and whether whole-genome sequencing might occur.

Required Elements of HIPAA Authorization

Core elements

• A specific description of the PHI to be used or disclosed (for example, medical records from defined dates, imaging, or lab results).
• The identity of who may use or disclose the PHI (such as a named provider or health system).
• Who may receive the PHI (for example, a researcher, sponsor, or third-party partner).
• The purpose of the use or disclosure (for example, a specified research study or a defined administrative purpose).
• Authorization Expiration stated as a date or event that is meaningful and measurable (for example, “end of the study” or a specific calendar date).
• Your right to revoke authorization in writing, how to do so, and what revocation means for PHI already used or disclosed.
• A statement about whether treatment, payment, enrollment, or eligibility for benefits is conditioned on signing (and the consequences of refusing, if conditioning is permitted).
• A notice that information disclosed to non-covered recipients may be redisclosed and no longer protected by HIPAA, subject to PHI Disclosure Restrictions under other laws or agreements.
• Your signature and date; if a personal representative signs, the description of authority to act for you.

Additional points often required

• Separate, specific authorization for psychotherapy notes, marketing, or sale of PHI when applicable.
• Right to receive a copy of the signed authorization for your records.

Differences Between Informed Consent and HIPAA Authorization

• Purpose: Informed consent safeguards ethical participation and Research Subject Rights; HIPAA authorization permits defined uses and disclosures of PHI under HIPAA Privacy Regulations.
• Focus: Consent explains procedures, risks, benefits, and alternatives; authorization specifies PHI details—what, who, to whom, why, and for how long.
• Regulatory oversight: Consent is overseen by an Institutional Review Board (and, when applicable, FDA); authorization is governed by the HIPAA Privacy Rule and enforced for Privacy Rule Compliance.
• Timing and duration: Consent persists while you participate and ends when you withdraw; authorization includes an Authorization Expiration or event and can be revoked in writing.
• Data scope: Consent may discuss data handling broadly; authorization precisely limits PHI flows consistent with PHI Disclosure Restrictions.
• Combination: Documents can be presented together for convenience, but signing one does not automatically satisfy the requirements of the other.

Conditions for Waiver or Alteration of Consent

Informed consent (research) — possible IRB waiver or alteration

• The research poses no more than minimal risk to participants.
• The waiver or alteration will not adversely affect participants’ rights and welfare.
• The research could not practicably be carried out without the waiver or alteration.
• When appropriate, you will receive additional pertinent information after participation.

HIPAA authorization — possible IRB or Privacy Board waiver or alteration

• Minimal risk to privacy based on: a plan to protect identifiers, a plan to destroy identifiers at the earliest opportunity, and written assurances against improper reuse or disclosure.
• The research could not practicably be conducted without the waiver or alteration and could not practicably be conducted without access to and use of PHI.

Other Privacy Rule pathways that do not require authorization

• Use of de-identified information (no longer PHI) or a limited data set under a data use agreement.
• Research solely on decedents’ information or activities preparatory to research, each with specific conditions.

Summary

Use informed consent to protect autonomy and clarify participation; use HIPAA authorization to control specific PHI disclosures under HIPAA Privacy Regulations. When both apply, satisfy each independently. Waivers exist but require strict IRB or Privacy Board review and documentation to maintain Privacy Rule Compliance and Research Subject Rights.

FAQs

What is the main difference between informed consent and HIPAA authorization?

Informed consent confirms that you understand and voluntarily agree to take part in an activity—typically research—protecting your Research Subject Rights. HIPAA authorization is a privacy permission that allows a covered entity to use or disclose your Protected Health Information for specified purposes under HIPAA Privacy Regulations.

When is HIPAA authorization required instead of informed consent?

HIPAA authorization is required whenever a use or disclosure of PHI is not otherwise permitted by the Privacy Rule, such as many research disclosures from a health system to a study team. Even if you give informed consent to participate, you still may need to authorize PHI sharing, including setting an Authorization Expiration and recognizing PHI Disclosure Restrictions.

Can an Institutional Review Board waive informed consent requirements?

Yes. An Institutional Review Board may waive or alter informed consent when the research involves no more than minimal risk, rights and welfare are not adversely affected, the research is impracticable without the waiver, and, when appropriate, you receive pertinent information afterward.

What are the key elements that must be included in HIPAA authorization?

You should see a description of the PHI involved; who may use or disclose it; who may receive it; the purpose; an Authorization Expiration (date or event); your right to revoke and how; statements about any conditioning of services; a redisclosure notice; and your signature and date (plus representative authority if applicable).